Patients are getting surgeries again as COVID-19 worries wane Article_Normal HEAD TOPICS

Patients are getting surgeries again as COVID-19 worries wane

10/21/2022 9:57:00 AM

J& J said surgical procedure volumes are returning to pre-pandemic levels in many parts of the world

Article_Normal Medical Equipment Supplies

Source

MarketWatch

Johnson & Johnson said its medical-technology business had a “strong September,” with U.S. sales of hip and knee implants and other surgical devices rising 7.7% to $3.3 billion in the third quarter of the year. J&J said surgical procedure volumes are returning to pre-pandemic levels in many parts of the world. J&J, which reported earnings on Tuesday, said its medical-technology business had a “strong September,” with U.S. sales of hip and knee implants and other surgical devices rising 7.7% to $3.3 billion in the third quarter of the year. That said, global sales were down 2.9%, which executives attributed to a slow August in Europe for the holiday season and pre-pandemic volume levels in China. “We are seeing procedures recovering,” Ashley McEvoy, J&J’s worldwide chair of its MedTech business, told investors during this week’s earnings call. “In the United States, we started to see surgical procedures tick up, predominantly at the latter part of the quarter.” Read more:
MarketWatch » A bionic device may help COVID-19 survivors smell again, researchers suggest COVID-19 is still a global health emergency, WHO says COVID-19 is still a global health emergency, WHO says Ohio urges COVID-19 booster shots as new variants emerge

A head of lettuce bests Liz Truss in tabloid Prime minister race CNN Business

Liz Truss has been outlasted by a lettuce in a British tabloid live stream contest. CNN's Anna Stewart reports. Read more >> A bionic device may help COVID-19 survivors smell again, researchers suggestVCU researchers' newly developed bionic device could help COVID-19 survivors to smell again. COVID-19 is still a global health emergency, WHO saysThe announcement comes as a new COVID variant known as BQ.1 infects globally. Dr. Anthony Fauci described the spread of BQ.1 as “pretty troublesome” last week. Nope. Never listen to that man. Nope. Nah 😂😂😂😂😂😂😂😂😂😂 COVID-19 is still a global health emergency, WHO saysThe World Health Organization said that the COVID-19 pandemic continues to be classified as a Public Health Emergency of International Concern (PHEIC), almost three years after it was first recognized as such back in January 2020. As Corrupt GOP Trump & His GOP cohorts in crime tried to dismiss it & its prevention early on in a few weeks/few months, 'like the annual Fleu it will be gone! Ohio urges COVID-19 booster shots as new variants emergeNewest COVID-19 strains have gained the attention of top health experts. Why Experts Are Warning About 'Troublesome' COVID Variants BQ.1 and BQ.1.1This duo now makes up more than 11% of COVID-19 cases in the U.S. Johnson & Johnson JNJ, +0.As reported in IEEE , Costanzo, an emeritus professor of physiology and biophysics who cofounded VCU's Smell and Taste Disorders Center in the 1980s, one of the country's first such clinics, may consider this effort to be his most significant professional accomplishment."While the global situation has obviously improved since the pandemic began, the virus continues to change, and there remain many risks and uncertainties," Adhanom said.These Cars Have No Problem Getting Past 250,000 Miles - Is Yours on the List? The Tennessean SEC basketball order of finish: USA TODAY Sports Network experts rank league teams 1-14 in predicting how 2022-23 league race will play out. 26% said surgical procedure volumes are returning to pre-pandemic levels in many parts of the world, a trend that cheered Wall Street and could bode well for other medical-technology heavyweights like Stryker Corp. SYK, -1. "Thanks to COVID, this has become an area of more interest to investors,” also said Daniel Coelho in Nature.04% and Zimmer Biomet Holdings Inc. A PHEIC could require a coordinated international response effort, and is often"serious, sudden, unusual or unexpected. ZBH, -1.” It started before COVID-19 The study took off in 2011 when he started conversing with his colleague Daniel Coelho, a VCU professor of otolaryngology and cochlear implant expert.66%. Since the end of 2020, Switzerland has got 31. J&J, which reported earnings on Tuesday, said its medical-technology business had a “strong September,” with U. Most Popular "It’s taking something from the physical world and translating it into electrical signals that strategically target the brain,” Dr.1 as"pretty troublesome.S. sales of hip and knee implants and other surgical devices rising 7. The two researchers' olfactory-implant system was also given a U.7% to $3.1, have already grown to make up more than 10% of new infections across the U.3 billion in the third quarter of the year. patent in 2016. consumer protection watchdog's funding unconstitutional, court rules (Reuters) -A federal appeals court ruled on Wednesday that the U. That said, global sales were down 2.9%, which executives attributed to a slow August in Europe for the holiday season and pre-pandemic volume levels in China. Costanzo and Dr. “We are seeing procedures recovering,” Ashley McEvoy, J&J’s worldwide chair of its MedTech business, told investors during this week’s earnings call. “In the United States, we started to see surgical procedures tick up, predominantly at the latter part of the quarter. To avoid creating the false impression that a commercial device will soon be ready, Costanzo believes it would be better to be wary.” Over the course of the pandemic, surgical volumes declined as hospitals postponed or canceled elective procedures during COVID-19 surges and patients held off on medical care. Circuit Court of Appeals ruled that the CFPB's independent funding through the Federal Reserve rather than budgets passed by Congress violated the separation of powers principles in the U. One study published in JAMA Network Open in August found the recovery in surgical volume at Massachusetts General Hospital in Boston was inconsistent and insufficient through much of 2021. The team is currently working on improving the sensors' ability to detect more than a few odors and determining the optimal way to communicate with the brain. But that’s starting to change. Google searches for elective procedures made during the week of Oct. 9 were 108% higher than pre-pandemic levels, Needham analysts said this month. “There is patient demand that is still yet to be met,” McEvoy said. “And that’s really what we’re experiencing in quarter three, and we still think that will continue into 2023.” Abbott Laboratories ABT, -2.96%, which makes heart pumps and pacemakers, among other cardiac devices, also said this week that cardiovascular procedure volumes in the U.S. were soft in July but strengthened in August and September. The better-than-expected performance in J&J’s med-tech business in the third quarter has Stifel analysts “feeling cautiously optimistic” about Stryker and Zimmer, both of which make devices used in orthopedic procedures. The companies are set to share quarterly results on Oct. 31 and Nov. 2, respectively. J&J’s stock is down 3. 6% this year, while the S&P 500 SPX, -0.80% has declined 22.4%. .